Keep talking: The key to success in trial delivery
News
Zoe Boylan, Combinations Alliance (CA) Trial Manager within the ECMC Programme Office. The CA team have recently run a series of review meetings with Sponsor Clinical Trial Unit (CTU) teams and Chief Investigators to understand the key to sucess in trial delivery. Trial Setup It’s clear, at the outset each...
Recruiting for Molto Study
News
The Molto study has opened at the Christie Hospital, Manchester. The trial is recruiting women with a germline BRCA1/2 mutation and recurrent, platinum-sensitive, high-grade serous or endometrioid ovarian cancer.
Dr Ananya Choudhury wins ‘Outstanding Contribution’ category at the Greater Manchester Clinical Research Awards 2017
News
The winners of the 2017 Greater Manchester Clinical Research Awards were revealed during an evening of celebration on Thursday 9 November. Staff from across the region’s Trusts and GP practices gathered in Manchester city centre for the fifth-annual ceremony to toast excellence in health research delivery. Individuals and teams were...
WISTERIA - Experimental drug trial seeks to improve treatment for head and neck cancer
News
A trial to test an experimental drug in patients with head and neck cancer launches in the UK today (Friday), through the Combinations Alliance – a joint initiative between Cancer Research UK and the Experimental Cancer Medicine Centres (ECMC) Network. Researchers want to find out whether using Astra Zeneca’s AZD1775...
SMP2 and NLMT network 2017 Review
News
It has been yet another busy year for the Stratified Medicine Programme (SMP2) and the National Lung Matrix Trial (NLMT) so we would like to extend a huge thank you to all our colleagues for their continued hard work and support, as well as to all the patients and their families who signed up to this new, innovative trial.
SPOTLIGHT: Glasgow's PIONEER Trial
News
The PIONEER team in Glasgow has been working through the Combinations Alliance and having huge success in doing so. We caught up with them to find out more about their research.
Dr David Pinato of Imperial awarded CRUK Postdoctoral Bursary
News
Dr David Pinato has been awarded with a Cancer Research UK Postdoctoral Bursary for his project - Phenotypic characterisation of the anti-tumour immune response following loco-regional therapy of hepatocellular carcinoma. Trans-arterial chemoembolization (TACE) can enhance anti-tumour immunity in hepatocellular carcinoma (HCC). However, spontaneous immune responses to TACE are weak and...
Expression of Interest (EOI) Roundup
News
Thank you to all those involved in submitting an EOI to our recent call we recived a total of 41 EOIs. The call opened on 11 October, well attended webinars were held on 3 November and the call closed 30 November. The ECMC Combinations Alliance and the NIHR CRN Industry...
New ECMC Haematology Network Group Launched
News
Following interest expressed by centres across the ECMC network, a newly established ECMC Haematology Network Group, led by Cardiff ECMC, met for the first time on the 25 th October in the Hammersmith Hospital, with seven centres represented. A key objective of the group is to strengthen the representation of...
Ian Walker reflects on the ECMC network in 2017
News
2017 has been a busy year for the ECMC network. The new 5 year review officially started in April. With the renewed agreement of the 5 co-funders (CRUK; NIHR: CSO; HCRW; HSC), and on the back of a successful international peer review, we welcomed Liverpool back in the adult network,...